A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma.
about
Immune Cells in Cancer Therapy and Drug DeliveryCells as delivery vehicles for cancer therapeutics.Challenges in SN38 drug delivery: current success and future directions.Enzyme/Prodrug Systems for Cancer Gene Therapy.Stem cell-based photodynamic therapy.Magnetic-Fe/Fe(3)O(4)-nanoparticle-bound SN38 as carboxylesterase-cleavable prodrug for the delivery to tumors within monocytes/macrophages.
P2860
A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma.
@ast
A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma.
@en
type
label
A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma.
@ast
A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma.
@en
prefLabel
A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma.
@ast
A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma.
@en
P2093
P2860
P1476
A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma
@en
P2093
Carl Myers
Deryl L Troyer
Gwi-Moon Seo
Hongwang Wang
Marla Pyle
Masaaki Tamura
Matthew T Basel
Raja Shekar Rachakatla
Stefan H Bossmann
Tej B Shrestha
P2860
P2888
P304
P356
10.1007/S11033-011-0720-7
P577
2011-05-13T00:00:00Z